We are building the first desktop bioprinter for life science researchers.

Our proprietary enzyme-mediated DNA synthesis platform will enable the rapid and cost-effective production of highly accurate, ultra-long DNA products. We aim to be the key provider of long-length variant DNA and genome libraries for protein, biological pathway, and ultimately genome-scale engineering.

Stay up to date with Nuclera

Login or create a free user account to follow this company and see updates on your dashboard.

Create account